caa a22 4500 477054498 CHVBK 20180405111344.0 cr unu---uuuuu 170330e19961201xx s 000 0 eng 10.1007/BF02602953 doi (NATIONALLICENCE)springer-10.1007/BF02602953 Apolipoprotein AIV of human interstitial fluid is associated with apolipoprotein AI-containing but not with AII-containing particles [Elektronische Daten] [N. Ghalim, A. Adlouni, R. Saile, H. Parra, A. Benslimane, J. Bard, J. Fruchart] Apolipoproteins and lipoprotein particles from human interstitial fluid and plasma were analyzed. The interstitial fluid was enriched in apolipoproteins AI, AII, and AIV compared with apo B, apo CIII, and apo E. LpAI was found to contain apo AIV which was absent from LpAI: AII. Moreover, the bulk of lecithin-cholesterol acyltransferase was present in LpAI. The concentration range of these particles was in agreement with those required in vitro for cholesterol efflux. Thus the interstitial fluid contains particles in which two agonists but no antagonists of cholesterol efflux are associated with lecithin-cholesterol acyltransferase activity. This supports apolipoprotein AI-and/or AIV-containing particles playing a critical role in the first step of reverse cholesterol transport. Springer-Verlag, 1996 Apolipoprotein AIV nationallicence Apolipoprotein AI nationallicence Interstitial fluid nationallicence Immunoaffinity chromatography nationallicence Lecithin-cholesterol acyltransferase nationallicence Ghalim N. Laboratoire des Lipoprotéines, Institut Pasteur du Maroc, B.P. 120, Casablanca, Morocco aut Adlouni A. Laboratoire des Lipoprotéines, Institut Pasteur du Maroc, B.P. 120, Casablanca, Morocco aut Saile R. Laboratoire des Lipoprotéines, Institut Pasteur du Maroc, B.P. 120, Casablanca, Morocco aut Parra H. Service d'Expertise Pharmacologique, Institut Pasteur de Lille, B.P. 245, F-59019, Lille Cedex, France aut Benslimane A. Laboratoire des Lipoprotéines, Institut Pasteur du Maroc, B.P. 120, Casablanca, Morocco aut Bard J. Service d'Expertise Pharmacologique, Institut Pasteur de Lille, B.P. 245, F-59019, Lille Cedex, France aut Fruchart J. Département d'Athérosclérose (U325 INSERM), Institut Pasteur de Lille, Lille, France aut International Journal of Clinical and Laboratory Research Springer-Verlag 26/4(1996-12-01), 224-228 0940-5437 26:4<224 1996 26 599 https://doi.org/10.1007/BF02602953 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF02602953 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Ghalim N. Laboratoire des Lipoprotéines, Institut Pasteur du Maroc, B.P. 120, Casablanca, Morocco aut NATIONALLICENCE 700 1- Adlouni A. Laboratoire des Lipoprotéines, Institut Pasteur du Maroc, B.P. 120, Casablanca, Morocco aut NATIONALLICENCE 700 1- Saile R. Laboratoire des Lipoprotéines, Institut Pasteur du Maroc, B.P. 120, Casablanca, Morocco aut NATIONALLICENCE 700 1- Parra H. Service d'Expertise Pharmacologique, Institut Pasteur de Lille, B.P. 245, F-59019, Lille Cedex, France aut NATIONALLICENCE 700 1- Benslimane A. Laboratoire des Lipoprotéines, Institut Pasteur du Maroc, B.P. 120, Casablanca, Morocco aut NATIONALLICENCE 700 1- Bard J. Service d'Expertise Pharmacologique, Institut Pasteur de Lille, B.P. 245, F-59019, Lille Cedex, France aut NATIONALLICENCE 700 1- Fruchart J. Département d'Athérosclérose (U325 INSERM), Institut Pasteur de Lille, Lille, France aut NATIONALLICENCE 773 0- International Journal of Clinical and Laboratory Research Springer-Verlag 26/4(1996-12-01), 224-228 0940-5437 26:4<224 1996 26 599 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer